• Home
  • About
    • Our Approach
    • Guiding Principles
    • Leadership
    • Leadership in the News
    • Board of Directors
    • Scientific Advisory Board
    • Ophthalmology Advisory Board
  • Technology
    • Platform
    • Product Engine
  • Pipeline
    • Pipeline
    • Clinical Candidates
  • Scientific Presentations
  • Our Purpose
    • Ophthalmic Diseases
    • Pulmonary Diseases
    • Cardiology Diseases
  • Investors
  • Careers
    • Join our Team
    • Living our Guiding Principles
    • 4Diversity
    • What We Offer
    • Open Positions
  • Contact
  • Search
  • Menu Menu

Jacob Chacko, MD, MBA

Susannah Gray, MBA

Nancy Miller-Rich

Charles Theuer, MD, PhD

Shawn Tomasello, MBA

John P. Atkinson, MD

Ronald Crystal, MD

Napoleone Ferrara, MD

Amit Gaggar, MD, PhD

Douglas Hanahan, PhD

Page 3 of 41234

About 4DMT

Our 4DMT genetic medicine engine holds the potential to generate transformative therapies that have the power to improve patient lives, or even cure disease.

Navigation

  • Home
  • About
    • Our Approach
    • Guiding Principles
    • Leadership
    • Leadership in the News
    • Board of Directors
    • Scientific Advisory Board
    • Ophthalmology Advisory Board
  • Technology
    • Platform
    • Product Engine
  • Pipeline
    • Pipeline
    • Clinical Candidates
  • Scientific Presentations
  • Our Purpose
    • Ophthalmic Diseases
    • Pulmonary Diseases
    • Cardiology Diseases
  • Investors
  • Careers
    • Join our Team
    • Living our Guiding Principles
    • 4Diversity
    • What We Offer
    • Open Positions
  • Contact

Location

5858 Horton St. Suite 455
Emeryville, CA 94608

(510) 505-2680
info@4dmt.com

© 2025 4D Molecular Therapeutics. All rights reserved.

  • Contact
  • Privacy Notice
  • Site Terms
Scroll to top